Y-Intercept (HK)’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Y-Intercept (HK)'s VKTX Position: Q2 2026 in Review
Y-Intercept (HK) opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 72,440 shares worth $2.83M. The stake represents 0.06% of the portfolio and ranks #505 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in VKTX as recently as Q1 2025.
Y-Intercept (HK) first reported a position in VKTX in Q4 2023 and has held it in 3 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Y-Intercept (HK) held 72,440 shares of Viking Therapeutics worth $2.83M as of Q2 2026.
- Viking Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
- Viking Therapeutics made up 0.06% of Y-Intercept (HK)'s portfolio in Q2 2026, its #505 holding.
- Y-Intercept (HK) first reported a position in Viking Therapeutics in Q4 2023 and has held it in 3 quarters since.
- 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.